´
M.S. Arias-Perez et al. / Journal of Molecular Structure 644 (2003) 171–179
178
Table 7
1H–1H coupling constants for the a-hydroxyester 3
additionally stabilised by weak intramolecular hydro-
gen bonding with participation of the carbonyl oxygen
atom (O2) as hydrogen-bond acceptor, in accordance
with the IR results. Furthermore, this conformation
only involves a small distortion of the geometry
observed for 3 by X-ray diffraction.
In summary, it may be proposed that the quinucli-
dine system does not exert a significant influence on
the conformational preferences of the alkoxycarbonyl
moiety in the a-hydroxyesters 3–6. In the solid state,
the preferred conformation was found to be an almost
ideal staggered form, in which the carbonyl group
adopts a bisecting geometry with respect to the
hydroxy group and the bicyclic carbon C4. NMR
and IR data account for a conformational heterogen-
eity with a significant contribution of an almost
CyO/OH eclipsed form, stabilised by a weak
intramolecular hydrogen bond, in CDCl3 solution.
3J (Hz)
2J (Hz)
H4–H51
3.01
3.33
3.25
2.74
10.61
5.51
5.49
10.48
10.39
5.70
4.59
10.58
7.2
H21–H22a
H51–H52
H71–H72
H81–H82
214.2
H4–H52
213.10
213.27
213.10
H4–H81
H4–H82
4
H51–H61
H51–H62
H52–H61
H52–H62
H71–H81
H71–H82
H72–H81
H72–H82
H10–H11a
l Jl (Hz)
H21–H72a
H22–H62a
H51–H81
H61–H71
2.1
2.0
2.90
2.35
Values calculated from the analysis of the respective spin
subsystems by means of the LAOCOON III program; error ^0.05 Hz.
a
Values deduced from the analysis of the spectrum. The values of
these coupling constants are 2JH21–H22 ¼ 214.3 (4–6) and
4
213.9 (7); l JH21–H72l ¼ 2.1 (4 and 5), 2.2 (6 and 7).
Acknowledgements
network. With regard the alkoxy C–O bond, the
preference is for a planar Z conformation (O2–C9–
O1–C10 ¼ 238) as was expected [29].
´
This work was supported by the Spanish Comision
´
Interministerial de Ciencia y Tecnologıa (Project
´
2FD97-0388-C02-02) and the University of Alcala.
1
From the H and 13C parameters, which show a
great similarity, it can be assumed that in CDCl3
solution, the hydroxy and alkoxycarbonyl groups
exhibit the same behaviour. However, these data give
little information about the conformational prefer-
ences of these groups, which arises from the proton
chemical shifts. By comparing the a-hydroxyesters
3–6 and the parent 3-quinuclidinol 7, it was found
that the introduction of an alkoxycarbonyl group at the
3-position exerts a small deshielding effect on the H-
4, H-51 and C-2 protons (Table 6). The effect is
slightly greater for H-21, in a cis orientation
(Scheme 1) and the value of Dd H21–H22 ¼ 0.7–
0.8 ppm in derivatives 3–6 is near to that observed for
7 (0.5 ppm). These facts can tentatively be attributed
to a high flexibility of the alkoxycarbonyl moiety in
solution, suggesting a conformational equilibrium
between eclipsed and bisecting conformations by
rotation around the C–C(yO) (C3–C9) bond.
Although any preference can be unequivocally
asserted, it is reasonable to suppose that an almost
eclipsed orientation of the carbonyl group with
respect to O3 (OH group) should make a significant
contribution. This spatial disposition should be
References
´
[1] M.H. Aprison, E. Galvez, K.B. Lipkowitz, J. Neurosci. Res. 43
(1996) 127.
[2] R.A. Glennon, M. Dukat, Pharm. Acta Helv. 74 (2000) 103.
´
[3] A. Morreale, I. Iriepa, E. Galvez, Curr. Med. Chem. 9(2002)99.
[4] F.D. King, J.B. Jones, G.J. Sanger, 5-Hydroxytryptamine-3-
Receptor Antagonists, CRC Press, Boca Raton, FL, 1994.
[5] P. Krogsgaard-Larsen, B. Frlund, U. Kristiansen, K. Fryden-
vang, B. Ebert, Eur. J. Pharm. Sci. 2 (1997) 355.
´
[6] E. Galvez-Ruano, I. Iriepa, A. Morreale, D.B. Boyd, J. Mol.
Graphics Modell. 20 (2001) 183 and references cited therein.
´
´
[7] M.S. Arias-Perez, A. Cosme, E. Galvez, M.J. Santos, M.
Martinez-Ripoll, E. Matesanz, J. Mol. Struct. 565/566 (2001)
353.
[8] J. Saunders, M. Cassidy, S.B. Freedman, E.A. Harley, L.L.
Iversen, C. Kneen, A.M. McLeod, K.J. Merchant, R.J. Snow,
R. Baker, J. Med. Chem. 33 (1990) 1128.
[9] V.I. Cohen, R.E. Gibson, L.H. Fan, R. De la Cruz, M.S. Gitler,
E. Hariman, R.C. Reba, J. Med. Chem. 34 (1991) 2989.
[10] F.I. Carrol, P. Abraham, K. Parham, R.C. Griffith, A. Ahmad,
M.M. Richard, F.N. Padilla, J.M. Witkin, P.K. Chiang, J. Med.
Chem. 30 (1987) 805.
[11] V. Schmieden, H. Betz, Mol. Pharmacol. 48 (1995) 919.